| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 4204-4211, Copyright © 1996 by Endocrine Society
ARTICLES |
BT Teh, F Farnebo, U Kristoffersson, B Sundelin, J Cardinal, R Axelson, A Yap, M Epstein, H Heath 3rd, D Cameron and C Larsson
Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.
Hereditary hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease (OMIM 145001) that has recently been mapped to chromosomal region 1q21-q32 (HRPT2). Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome. In the first family, renal lesions were present in five out of six affected individuals, whereas HPT and JT were seen in four and two cases, respectively. In the second family, JT was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease. The possibility of the latter cosegregating as a separate autosomal dominant gene can not be ruled out. A sex-dependent penetrance of primary HPT, resulting in predominantly male-affected cases was evident in the two families. Twenty microsatellite markers in the HRPT2 region were typed, in addition to markers in the multiple endocrine neoplasia (MEN) types 1 and 2 regions at 11q13 and 10q11. The disease in these two kindreds was linked to five markers in the 1q21-q32 region (logarithm-of-odds scores: 3.2-4.2), whereas linkage to the MEN1 and MEN2 regions was excluded. Meiotic recombinations detected in affected individuals placed the locus telomeric of D1S215, thus narrowing the HRPT2 region from > 60 to approximately 34 centimorgans. Loss of heterozygosity was studied in seven renal hamartomas from two affected individuals in the first family, as well as in a jaw tumor and a parathyroid tumor from the second family. All renal hamartomas showed loss of heterozygosity at the 1q21-q32 region. The losses invariably involved the wild type allele derived from the unaffected parent, suggesting the inactivation of a tumor suppressor gene in this region.
This article has been cited by other articles:
 |
|
 |
|
  F. Raue and K. Frank-Raue Primary hyperparathyroidism--what the nephrologist should know--an update Nephrol. Dial. Transplant., March 1, 2007; 22(3): 696 - 699. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lin, M. Czapiga, L. Nini, J.-H. Zhang, and W. F. Simonds Nuclear Localization of the Parafibromin Tumor Suppressor Protein Implicated in the Hyperparathyroidism-Jaw Tumor Syndrome Enhances Its Proapoptotic Function Mol. Cancer Res., February 1, 2007; 5(2): 183 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R H Scott, C A Stiller, L Walker, and N Rahman Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour J. Med. Genet., September 1, 2006; 43(9): 705 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Marx and W. F. Simonds Imaging to detect early endocrine cancers. J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2861 - 2863. [Full Text] [PDF]
|
|
|
|
|
|
V. Guarnieri, A. Scillitani, L. A. Muscarella, C. Battista, N. Bonfitto, M. Bisceglia, S. Minisola, M. L. Mascia, L. D'Agruma, and D. E. C. Cole Diagnosis of Parathyroid Tumors in Familial Isolated Hyperparathyroidism with HRPT2 Mutation: Implications for Cancer Surveillance J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2827 - 2832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rubin and S. J. Silverberg HRPT2 in Parathyroid Cancer: A Piece of the Puzzle J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5505 - 5507. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K J Bradley, B M Cavaco, M R Bowl, B Harding, A Young, and R V Thakker Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism J. Med. Genet., August 1, 2005; 42(8): e51 - e51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-D. Moon, J.-H. Park, E.-M. Kim, J.-H. Kim, J.-H. Han, S.-J. Yoo, K.-H. Yoon, M.-I. Kang, K.-W. Lee, H.-Y. Son, et al. A Novel IVS2-1G>A Mutation Causes Aberrant Splicing of the HRPT2 Gene in a Family with Hyperparathyroidism-Jaw Tumor Syndrome J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cetani, E. Pardi, S. Borsari, P. Viacava, G. Dipollina, L. Cianferotti, E. Ambrogini, E. Gazzerro, G. Colussi, P. Berti, et al. Genetic Analyses of the HRPT2 Gene in Primary Hyperparathyroidism: Germline and Somatic Mutations in Familial and Sporadic Parathyroid Tumors J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5583 - 5591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Cavaco, L. Guerra, K. J. Bradley, D. Carvalho, B. Harding, A. Oliveira, M.-A. Santos, L. G. Sobrinho, R. V. Thakker, and V. Leite Hyperparathyroidism-Jaw Tumor Syndrome in Roma Families from Portugal Is Due to a Founder Mutation of the HRPT2 Gene J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1747 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Villablanca, A Calender, L Forsberg, A Hoog, J-D Cheng, D Petillo, C Bauters, K Kahnoski, T Ebeling, P Salmela, et al. Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP) J. Med. Genet., March 1, 2004; 41(3): e32 - 32. [Full Text] [PDF]
|
|
|
|
|
|
W. F. Simonds, C. M. Robbins, S. K. Agarwal, G. N. Hendy, J. D. Carpten, and S. J. Marx Familial Isolated Hyperparathyroidism Is Rarely Caused by Germline Mutation in HRPT2, the Gene for the Hyperparathyroidism-Jaw Tumor Syndrome J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 96 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Shattuck, S. Valimaki, T. Obara, R. D. Gaz, O. H. Clark, D. Shoback, M. E. Wierman, K. Tojo, C. M. Robbins, J. D. Carpten, et al. Somatic and Germ-Line Mutations of the HRPT2 Gene in Sporadic Parathyroid Carcinoma N. Engl. J. Med., October 30, 2003; 349(18): 1722 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V M Howell, C J Haven, K Kahnoski, S K Khoo, D Petillo, J Chen, G J Fleuren, B G Robinson, L W Delbridge, J Philips, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours J. Med. Genet., September 1, 2003; 40(9): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Takahashi, R Kahnoski, D Gross, D Nicol, and B T Teh Familial adult renal neoplasia J. Med. Genet., January 1, 2002; 39(1): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.M. Cavaco, L. Barros, A.A.J. Pannett, L. Ruas, M. Carvalheiro, M.M.A. Ruas, T. Krausz, M.A. Santos, L.G. Sobrinho, V. Leite, et al. The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred QJM, April 1, 2001; 94(4): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-o. Kanayama, W.-O. Lui, M. Takahashi, T. Naroda, D. Kedra, F. K. Wong, Y. Kuroki, Y. Nakahori, C. Larsson, S. Kagawa, et al. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma J. Med. Genet., March 1, 2001; 38(3): 165 - 170. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Haven, F. K. Wong, E. W. C. M. van Dam, R. van der Luijt, C. van Asperen, J. Jansen, C. Rosenberg, M. de Wit, J. Roijers, J. Hoppener, et al. A Genotypic and Histopathological Study of a Large Dutch Kindred with Hyperparathyroidism-Jaw Tumor Syndrome J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1449 - 1454. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Marx CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009. [Full Text]
|
|
|
|
 |
|
 S. A. Ebrahimi, E. H. Wang, A. Wu, R. R. Schreck, E. Passaro Jr., and M. P. Sawicki Deletion of Chromosome 1 Predicts Prognosis in Pancreatic Endocrine Tumors Cancer Res., January 1, 1999; 59(2): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Teh, S. Kytölä, F. Farnebo, L. Bergman, F. K. Wong, G. Weber, N. Hayward, C. Larsson, B. Skogseid, A. Beckers, et al. Mutation Analysis of the MEN1 Gene in Multiple Endocrine Neoplasia Type 1, Familial Acromegaly and Familial Isolated Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2621 - 2626. [Abstract] [Full Text]
|
|
|
|
|
|
B. T. Teh, F. Farnebo, S. Twigg, A. Höög, S. Kytölä, E. Korpi-Hyövälti, F. K. Wong, J. Nordenström, L. Grimelius, K. Sandelin, et al. Familial Isolated Hyperparathyroidism Maps to the Hyperparathyroidism-Jaw Tumor Locus in 1q21-q32 in a Subset of Families J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2114 - 2120. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
